Epigenetics as biomarkers in autoimmune diseases

Copyright © 2018 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 196(2018) vom: 15. Nov., Seite 34-39
1. Verfasser: Wu, Haijing (VerfasserIn)
Weitere Verfasser: Liao, Jieyue, Li, Qianwen, Yang, Ming, Zhao, Ming, Lu, Qianjin
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Review Autoimmune diseases Biomarkers Epigenetics SLE Genetic Markers
LEADER 01000naa a22002652 4500
001 NLM282294279
003 DE-627
005 20231225033607.0
007 cr uuu---uuuuu
008 231225s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2018.03.011  |2 doi 
028 5 2 |a pubmed24n0940.xml 
035 |a (DE-627)NLM282294279 
035 |a (NLM)29574040 
035 |a (PII)S1521-6616(18)30118-9 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Wu, Haijing  |e verfasserin  |4 aut 
245 1 0 |a Epigenetics as biomarkers in autoimmune diseases 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 14.10.2019 
500 |a Date Revised 14.10.2019 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2018 Elsevier Inc. All rights reserved. 
520 |a Autoimmune diseases are immune system disorders in which immune cells cannot distinguish self-antigens from foreign ones. The current criteria for autoimmune disease diagnosis are based on clinical manifestations and laboratory tests. However, none of these markers shows both high sensitivity and specificity. In addition, some autoimmune diseases, for example, systemic lupus erythematosus (SLE), are highly heterogeneous and often exhibit various manifestations. On the other hand, certain autoimmune diseases, such as Sjogren's syndrome versus SLE, share similar symptoms and autoantibodies, which also causes difficulties in diagnosis. Therefore, biomarkers that have both high sensitivity and high specificity for diagnosis, reflect disease activity and predict drug response are necessary. An increasing number of publications have proposed the abnormal epigenetic modifications as biomarkers of autoimmune diseases. Therefore, this review will comprehensively summarize the epigenetic progress in the pathogenesis of autoimmune disorders and unearth potential biomarkers that might be appropriate for disease diagnosis and prediction 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Review 
650 4 |a Autoimmune diseases 
650 4 |a Biomarkers 
650 4 |a Epigenetics 
650 4 |a SLE 
650 7 |a Biomarkers  |2 NLM 
650 7 |a Genetic Markers  |2 NLM 
700 1 |a Liao, Jieyue  |e verfasserin  |4 aut 
700 1 |a Li, Qianwen  |e verfasserin  |4 aut 
700 1 |a Yang, Ming  |e verfasserin  |4 aut 
700 1 |a Zhao, Ming  |e verfasserin  |4 aut 
700 1 |a Lu, Qianjin  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 196(2018) vom: 15. Nov., Seite 34-39  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:196  |g year:2018  |g day:15  |g month:11  |g pages:34-39 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2018.03.011  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 196  |j 2018  |b 15  |c 11  |h 34-39